Using a smartwatch to diagnose heart rhythm issues
Accuracy of Cardiac Arrhythmias and Conduction Disorders Diagnosis Using Smartwatch in Comparison to Conventional Electrocardiogram in Patients With Cardiovascular Disease
This study is testing if a smartwatch can accurately detect heart rhythm problems in people with heart conditions compared to standard heart tests.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 110 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Federal University of Piaui Academic / other |
| Locations | 1 site (Teresina, Piauí) |
| Trial ID | NCT04437914 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the accuracy of electrocardiographic readings obtained from a smartwatch compared to traditional electrocardiograms in patients with cardiovascular diseases. It will analyze the similarities between the readings from both methods and assess the practicality of using smartwatches in clinical cardiology. The study will involve a sample of 110 patients who meet specific cardiovascular criteria, and it will focus on the effectiveness and reliability of smartwatch technology in diagnosing cardiac arrhythmias and conduction disorders.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with various cardiovascular conditions such as hypertension, heart failure, or arrhythmias.
Not a fit: Patients with poor quality electrocardiographic tracings that hinder diagnosis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance early diagnosis and monitoring of cardiac conditions, leading to improved patient outcomes.
How similar studies have performed: While the use of smartwatches for health monitoring is gaining traction, this specific approach to diagnosing cardiac arrhythmias is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years; * Presence of one or more of the following diagnoses: systemic arterial hypertension, heart failure, valve disease, coronary atherosclerotic disease, myocardial infarction, endocarditis, myocarditis, diabetes, cardiac arrhythmias and patients with cardiac pacemakers or implantable automatic defibrillators. Exclusion Criteria: * Patients who have electrocardiographic tracings, whether obtained from the watch or the conventional method, of poor quality that make it impossible or that makes the diagnosis difficult due to the technical aspect of the performance. * Withdrawal of the consent form at the request of the patient or guardian.
Where this trial is running
Teresina, Piauí
- Carlos Eduardo B. de Lima — Teresina, Piauí, Brazil (Recruiting)
Study contacts
- Principal investigator: Carlos Eduardo B de Lima, MD, PhD — Federal University of Piaui
- Study coordinator: Carlos Eduardo B. Lima, MD, PhD
- Email: carlos.lima@ufpi.edu.br
- Phone: +5586981805000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.